Why DYN? Dyne Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
DYN
$17.47-0.24 (-1.36%)
Pre-Market$19.22+1.75 (+10.02%)· Last close May 5
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.